Your browser doesn't support javascript.
Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic.
Machida, Masaki; Nakamura, Itaru; Kojima, Takako; Saito, Reiko; Nakaya, Tomoki; Hanibuchi, Tomoya; Takamiya, Tomoko; Odagiri, Yuko; Fukushima, Noritoshi; Kikuchi, Hiroyuki; Amagasa, Shiho; Watanabe, Hidehiro; Inoue, Shigeru.
  • Machida M; Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo 160-8402, Japan.
  • Nakamura I; Department of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo 160-0023, Japan.
  • Kojima T; Department of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo 160-0023, Japan.
  • Saito R; Department of International Medical Communications, Tokyo Medical University, Tokyo 160-0023, Japan.
  • Nakaya T; Division of International Health (Public Health), Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
  • Hanibuchi T; Graduate School of Environmental Studies, Tohoku University, Miyagi 980-0845, Japan.
  • Takamiya T; Graduate School of Environmental Studies, Tohoku University, Miyagi 980-0845, Japan.
  • Odagiri Y; Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo 160-8402, Japan.
  • Fukushima N; Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo 160-8402, Japan.
  • Kikuchi H; Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo 160-8402, Japan.
  • Amagasa S; Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo 160-8402, Japan.
  • Watanabe H; Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo 160-8402, Japan.
  • Inoue S; Department of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo 160-0023, Japan.
Vaccines (Basel) ; 9(3)2021 Mar 03.
Article in English | MEDLINE | ID: covidwho-1125918
ABSTRACT
Vaccination could be a key protective measure against coronavirus disease 2019 (COVID-19), and it is important to understand the acceptability of the COVID-19 vaccine among the general public. However, there is no study on the acceptance of a COVID-19 vaccine in Japan. Therefore, this study aimed to describe the COVID-19 vaccine acceptance and hesitancy situation in Japan and assess the factors associated with such issues. This was a cross-sectional study based on an internet survey completed by 2956 people. Participants were asked to indicate how likely they were to get vaccinated for COVID-19. In addition, the participants responded to questions regarding sociodemographic factors, attitudes, and beliefs regarding COVID-19 infection and vaccination. The proportion of participants with a high likelihood of getting a COVID-19 vaccine was 62.1%. Multiple logistic regression analysis showed that vaccine acceptance was lower among several sociodemographic groups, such as women, adults aged 20-49 years, and those with a low-income level. Several psychological factors, especially the perceived effectiveness of the COVID-19 vaccine, and willingness to protect others by getting oneself vaccinated, were associated with vaccine acceptance. Our results indicate that the perceived effectiveness of the vaccine and willingness to protect others may play an important role in the acceptance of the COVID-19 vaccine.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Language: English Year: 2021 Document Type: Article Affiliation country: Vaccines9030210

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Language: English Year: 2021 Document Type: Article Affiliation country: Vaccines9030210